799255-55-3 Usage
Uses
Used in Pharmaceutical Industry:
(S)-1-(2-piperidino-phenyl)-3-methyl-1-butyl-N-4-methoxybenzyl-ammonium L-mandelate is used as a potential pharmaceutical compound for its unique structure and potential biological activity. (S)-1-(2-piperidino-phenyl)-3-methyl-1-butyl-N-4-methoxybenzyl-ammonium L-mandelate's specific application reason is its potential to be developed into new drugs or treatments, contributing to advancements in medicine.
Used in Drug Development:
In the field of drug development, (S)-1-(2-piperidino-phenyl)-3-methyl-1-butyl-N-4-methoxybenzyl-ammonium L-mandelate is used as a starting material or a structural component for designing new drugs. Its unique molecular architecture may offer novel mechanisms of action or selectivity profiles, which could be beneficial for treating various medical conditions.
Used in Research and Development:
(S)-1-(2-piperidino-phenyl)-3-methyl-1-butyl-N-4-methoxybenzyl-ammonium L-mandelate is also used in research and development as a tool to study the interactions between biological molecules and potential drug candidates. Its unique structure can provide insights into the binding properties and mechanisms of action, which are crucial for understanding how drugs work and how they can be improved.
Check Digit Verification of cas no
The CAS Registry Mumber 799255-55-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,9,2,5 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 799255-55:
(8*7)+(7*9)+(6*9)+(5*2)+(4*5)+(3*5)+(2*5)+(1*5)=233
233 % 10 = 3
So 799255-55-3 is a valid CAS Registry Number.
799255-55-3Relevant academic research and scientific papers
METHOD FOR THE PRODUCTION OF PHENYLACETIC ACID DERIVATIVES
-
Page/Page column 11-12, (2010/02/09)
Disclosed is a method for producing (S) (+) phenylacetic acid derivatives of general formula (I), wherein R1 represents a linear or branched alkyl radical with 1 to 6 carbon atoms or optionally substituted benzyl while R2 represents methyl, ethyl, or propyl. The inventive method is characterized in that a compound of general formula (II), wherein R1 has the meaning indicated above and R3 represents a nucleofuge, or a suitable salt of a compound of general formula (II) is reacted with a compound of general formula (III), wherein R2 has the meaning indicated above and R4 represents hydrogen or a hydrolytically cleavable nucleofuge, whereupon the optionally provided protective group R4 is eliminated.
